Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression
- PMID: 37294002
- DOI: 10.1080/00015385.2023.2218025
Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression
Abstract
Background: Transcatheter aortic valve implantation (TAVI) has been established as a reasonable alternative to surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis. However, long-term outcomes including valve durability and the need for reintervention are unanswered, especially in younger patients who tend to be low surgical risk. We performed a meta-analysis comparing clinical outcomes after TAVI and SAVR over 5 years stratified to low, intermediate, and high surgical risks.
Methods: We identified propensity score-matched observational studies and randomised controlled trials comparing TAVI and SAVR. Primary outcomes, including all-cause mortality, moderate or severe aortic regurgitation, moderate or severe paravalvular regurgitation, pacemaker placement, and stroke, were extracted. Meta-analyses of outcomes after TAVI compared to SAVR were conducted for different periods of follow-up. Meta-regression was also performed to analyse the correlation of outcomes over time.
Results: A total of 36 studies consisting of 7 RCTs and 29 propensity score-matched studies were selected. TAVI was associated with higher all-cause mortality at 4-5 years in patients with low or intermediate surgical risk. Meta-regression time demonstrated an increasing trend in the risk of all-cause mortality after TAVI compared with SAVR. TAVI was generally associated with a higher risk of moderate or severe aortic regurgitation, moderate or severe paravalvular regurgitation, and pacemaker placement.
Conclusions: TAVI demonstrated an increasing trend of all-cause mortality compared with SAVR when evaluated over a long-term follow-up. More long-term data from recent studies using newer-generation valves and state-of-the-art techniques are needed to accurately assign risks.
Keywords: SAVR; TAVI; TAVR; aortic stenosis; meta-analysis; mortality.
Plain language summary
Transcatheter aortic valve implantation (TAVI) was associated with increased all-cause mortality at longer periods of follow-up irrespective of surgical risk. Aortic regurgitation, paravalvular regurgitation, major vascular complications, and pacemaker placement favoured surgical aortic valve replacement (SAVR) over TAVI. TAVI remained superior to SAVR in major bleeding and renal failure events. Long-term data on newer generation valves and up-to-date implantation techniques may provide better durability and improved outcomes after TAVI.
Similar articles
-
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.BMJ Open. 2021 Dec 6;11(12):e054222. doi: 10.1136/bmjopen-2021-054222. BMJ Open. 2021. PMID: 34873012 Free PMC article.
-
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.Cochrane Database Syst Rev. 2019 Dec 20;12(12):CD013319. doi: 10.1002/14651858.CD013319.pub2. Cochrane Database Syst Rev. 2019. PMID: 31860123 Free PMC article.
-
Transcatheter versus surgical aortic valve replacement in moderate and high-risk patients: a meta-analysis.Eur J Cardiothorac Surg. 2017 Apr 1;51(4):644-652. doi: 10.1093/ejcts/ezw388. Eur J Cardiothorac Surg. 2017. PMID: 28007879
-
Comparison of Valve Durability and Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Symptomatic Aortic Stenosis and Less-Than-High-Risk for Surgery.Am J Cardiol. 2020 Apr 15;125(8):1202-1208. doi: 10.1016/j.amjcard.2020.01.015. Epub 2020 Jan 28. Am J Cardiol. 2020. PMID: 32085868
-
Surgical versus transcatheter treatment of aortic valve stenosis-a meta-analysis of low-risk randomized trials with completed 5-year follow-up.Eur J Cardiothorac Surg. 2025 Jul 1;67(7):ezaf215. doi: 10.1093/ejcts/ezaf215. Eur J Cardiothorac Surg. 2025. PMID: 40580456
Cited by
-
Long-term age-stratified outcomes after surgical and transcatheter aortic valve replacement: a Dutch cohort study.Neth Heart J. 2025 May;33(5):172-179. doi: 10.1007/s12471-025-01944-5. Epub 2025 Apr 11. Neth Heart J. 2025. PMID: 40214963 Free PMC article.
-
Comparison of different timings of percutaneous coronary intervention in patients with transcatheter aortic valve implantation: a network meta-analysis.Front Cardiovasc Med. 2025 Aug 1;12:1596208. doi: 10.3389/fcvm.2025.1596208. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40822015 Free PMC article.
-
Sutureless aortic valve and post-operative atrial fibrillation: Five-year outcomes from a propensity matched cohort study.World J Cardiol. 2025 Apr 26;17(4):102669. doi: 10.4330/wjc.v17.i4.102669. World J Cardiol. 2025. PMID: 40308620 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources